Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - INNOVATIVE INDUSTRIAL PROPERTIES INC | v461993_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - INNOVATIVE INDUSTRIAL PROPERTIES INC | v461993_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - INNOVATIVE INDUSTRIAL PROPERTIES INC | v461993_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - INNOVATIVE INDUSTRIAL PROPERTIES INC | v461993_ex23-1.htm |
| EX-21.1 - EXHIBIT 21.1 - INNOVATIVE INDUSTRIAL PROPERTIES INC | v461993_ex21-1.htm |
| 10-K - 10-K - INNOVATIVE INDUSTRIAL PROPERTIES INC | v461993_10k.htm |
Exhibit 23.2
Consent of Independent Public Accounting Firm
Innovative Industrial Properties, Inc.
San Diego, California
We hereby consent to the use in the December 31, 2016 annual report on Form 10-K (the "Annual Report") of Innovative Industrial Properties, Inc. (the "Company") and the incorporation by reference in the Company's registration statement on Form S-8 (No. 333-214919) of our report dated March 8, 2017, relating to the consolidated financial statements and supplementary information of PharmaCann LLC and subsidiaries, which comprise the consolidated balance sheets as of December 31, 2016 and December 31, 2015 and the related consolidated statements of income, members’ equity, and cash flows for the year then ended, and the related notes to the consolidated financial statements and which are contained in that Annual Report.
/s/ Martin, Hood, Friese & Associates, LLC
Martin, Hood, Friese & Associates, LLC
Champaign, Illinois
March 23, 2017